RE:RE:Insiders buyingDr. Benedek (the CEO) did indeed invest $5 million of his own funds in the most recent $60m bought deal. He owns half the company.
| Filed 2022-04-19 11:14 Tx date 2022-04-19 | $ANRG
Anaergia Inc. | Benedek, Andrew 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Subordinate Voting Shares 15 - Acquisition or disposition under a prospectus | $5,000,000
+400,000 vol
$12.50 each | 400,000 |
"As part of the Offering and pursuant to his pre-emptive rights, Dr. Andrew Benedek, the Chair and Chief Executive Officer of the Company, has agreed to purchase approximately $5 million of the Shares, being 400,000 Shares, at the Issue Price as part of the Offering. Dr. Benedek currently holds an approximate 54.8% economic interest and 82.9% voting interest in the Company through ownership of multiple voting shares of the Company. Upon closing of the Offering, Dr. Benedek will hold an approximate 51.0% economic interest and 80.7% voting interest in the Company (or 50.4% economic interest and 80.3% voting interest assuming the exercise in full of the Over-Allotment Option"
https://www.globenewswire.com/en/news-release/2022/03/30/2413301/0/en/Anaergia-Inc-Announces-60-Million-Bought-Deal-Offering-of-Subordinate-Voting-Shares.html
SilverSpewn wrote: The Ink Company Insider reports disagree with you (they show 8k in selling for ANRG insiders and 120k buying from XBC insiders). Can you share your sources?